Alamar Biosciences, Inc. (California) (ALMR)
30.69
+0.97
(+3.26%)
USD |
NASDAQ |
Oct 23, 16:00
30.69
0.00 (0.00%)
After-Hours: 20:00
Alamar Biosciences Price to Book Value : 6.807 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 6.807 |
| October 22, 2026 | 6.592 |
| October 21, 2026 | 6.975 |
| October 20, 2026 | 6.246 |
| October 19, 2026 | 5.833 |
| October 16, 2026 | 5.607 |
| October 15, 2026 | 6.081 |
| October 14, 2026 | 5.627 |
| October 13, 2026 | 5.216 |
| October 12, 2026 | 5.376 |
| October 09, 2026 | 5.605 |
| October 08, 2026 | 5.746 |
| October 07, 2026 | 6.159 |
| October 06, 2026 | 7.155 |
| October 05, 2026 | 8.457 |
| October 02, 2026 | 7.621 |
| October 01, 2026 | 7.199 |
| September 30, 2026 | 7.556 |
| September 29, 2026 | 7.241 |
| September 28, 2026 | 7.232 |
| September 25, 2026 | 7.275 |
| September 24, 2026 | 7.363 |
| September 23, 2026 | 7.128 |
| September 22, 2026 | 7.368 |
| September 21, 2026 | 7.774 |
| Date | Value |
|---|---|
| September 18, 2026 | 7.729 |
| September 17, 2026 | 7.099 |
| September 16, 2026 | 6.516 |
| September 15, 2026 | 6.376 |
| September 14, 2026 | 6.208 |
| September 11, 2026 | 6.186 |
| September 10, 2026 | 6.159 |
| September 09, 2026 | 6.423 |
| September 08, 2026 | 6.642 |
| September 04, 2026 | 6.831 |
| September 03, 2026 | 6.78 |
| September 02, 2026 | 6.762 |
| September 01, 2026 | 6.512 |
| August 31, 2026 | 6.773 |
| August 28, 2026 | 6.811 |
| August 27, 2026 | 7.319 |
| August 26, 2026 | 7.558 |
| August 25, 2026 | 7.323 |
| August 24, 2026 | 7.252 |
| August 21, 2026 | 7.594 |
| August 20, 2026 | 7.683 |
| August 19, 2026 | 7.882 |
| August 18, 2026 | 7.310 |
| August 17, 2026 | 7.126 |
| August 14, 2026 | 7.354 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Personalis, Inc. | 7.169 |
| 10X Genomics, Inc. | 11.29 |
| Champions Oncology, Inc. | 16.88 |
| Medpace Holdings, Inc. | 31.92 |
| Avantor, Inc. | 2.078 |
Price to Book Value Related Metrics
| PS Ratio | 25.12 |
| Price | 30.69 |
| Earnings Yield | -2.31% |
| Market Cap | 2.130B |